NanJing Pharmaceutical Company Limited (600713.SS)

CNY 5.2

(-0.38%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 28.5 Billion 31.65 Billion 25.88 Billion 23.4 Billion 21.96 Billion 19.55 Billion
Total Current Assets 26.01 Billion 29.26 Billion 23.45 Billion 21.16 Billion 19.74 Billion 17.7 Billion
Cash And Short Term Investments 2.37 Billion 2.32 Billion 2.09 Billion 1.47 Billion 2.1 Billion 2.26 Billion
Cash and Cash Equivalents 2.37 Billion 2.32 Billion 2.09 Billion 1.47 Billion 2.1 Billion 2.26 Billion
Short Term Investments - -82.64 Million -123.63 Million -159.34 Million -165.22 Million 231.67 Million
Net Receivables 16.86 Billion 20.95 Billion 16.77 Billion 15.54 Billion 13.85 Billion 12.4 Billion
Inventory 5.79 Billion 5.78 Billion 4.51 Billion 4.06 Billion 3.71 Billion 2.94 Billion
Other Current Assets 975.67 Million 192.6 Million 71.96 Million 79.88 Million 75.97 Million 91.93 Million
Total Non-Current Assets 2.49 Billion 2.38 Billion 2.42 Billion 2.24 Billion 2.21 Billion 1.85 Billion
Net PPE 1.51 Billion 1.51 Billion 1.49 Billion 1.18 Billion 1.17 Billion 1.09 Billion
Good Will And Intangible Assets 291.14 Million 317.45 Million 340.27 Million 356.33 Million 329.61 Million 205.16 Million
Good Will 72.16 Million 72.16 Million 72.16 Million 74.16 Million 74.16 Million 13.52 Million
Intangible Assets 218.97 Million 245.28 Million 268.11 Million 282.16 Million 255.44 Million 191.64 Million
Long-Term Investments 328.97 Million 289.08 Million 377.81 Million 483.46 Million 525.31 Million 1.00
Tax Assets 322.35 Million 224.92 Million 180.78 Million 185.92 Million 173.83 Million 165.69 Million
Other Non Current Assets 43.34 Million 38.94 Million 36.84 Million 32.35 Million 11.03 Million 389.14 Million
Other Assets 1.00 1.00 1.00 - - -
Total Liabilities 20.95 Billion 24.95 Billion 20.65 Billion 18.58 Billion 17.44 Billion 15.44 Billion
Total Current Liabilities 18.56 Billion 22.28 Billion 17.52 Billion 17.2 Billion 17.12 Billion 15.14 Billion
Account Payables 6.9 Billion 10.13 Billion 8.06 Billion 7.63 Billion 7.59 Billion 6.55 Billion
Tax Payables 91.47 Million 267.25 Million 308.79 Million 226.16 Million 179.55 Million 179.71 Million
Short Term Debt 9.37 Billion 3.28 Billion 3.74 Billion 5.11 Billion 3.16 Billion 3.03 Billion
Deferred Revenue 103.57 Million 219.12 Million 3.03 Billion 3.3 Billion 2.73 Billion 179.71 Million
Other Current Liabilities 2.17 Billion 8.64 Billion 2.67 Billion 1.15 Billion 3.63 Billion 5.37 Billion
Total Non Current Liabilities 2.39 Billion 2.67 Billion 3.12 Billion 1.38 Billion 323.26 Million 302.55 Million
Long-Term Debt 2.11 Billion 2.32 Billion 2.75 Billion 1.02 Billion 8.52 Million 62.96 Million
Deferred Revenue Non Current 297.06 Million 293.16 Million 304.6 Million 265.33 Million 220.14 Million 205.87 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -178.03 Million 1.00 1.00 2.51 Million - 1.00
Other Liabilities 1.00 1.00 1.00 1.00 1.00 1.00
Total Equity 7.25 Billion 6.69 Billion 5.23 Billion 4.82 Billion 4.51 Billion 4.1 Billion
Stock Holders Equity 6.43 Billion 5.99 Billion 4.6 Billion 4.25 Billion 4.01 Billion 3.66 Billion
Common Stock 1.31 Billion 1.31 Billion 1.04 Billion 1.04 Billion 1.04 Billion 1.04 Billion
Retained Earnings 2.33 Billion 1.97 Billion 1.58 Billion 1.22 Billion 970.17 Million 744.77 Million
Accumulated other comprehensive income 635.24 Million 567.97 Million 603.5 Million 616.01 Million 611.79 Million 495.52 Million
Common Stock Equity 6.43 Billion 5.99 Billion 4.6 Billion 4.25 Billion 4.01 Billion 3.66 Billion
Capital Lease Obligation 119.02 Million 103.23 Million 124.39 Million 180.66 Million 8.52 Million 62.96 Million
Total Investments 328.97 Million 206.44 Million 254.18 Million 324.11 Million 360.08 Million 231.67 Million
Total Debt 11.61 Billion 5.6 Billion 6.49 Billion 6.14 Billion 3.16 Billion 3.03 Billion
Net Debt 9.24 Billion 3.28 Billion 4.4 Billion 4.66 Billion 1.06 Billion 773.48 Million

Balance Sheet Charts